David Wilkie
- Co-authors
- Richard NicholasJeremy ChatawayChris FrostDennis ChanCasper NielsenNadine SchuererAli AlsanousiK.R. Hunter
- Topics
- Multiple Sclerosis Research Studies (5 papers)Patient-Provider Communication in Healthcare (3 papers)Vaccine Coverage and Hesitancy (2 papers)
- Partner nations
- United KingdomItalyGermany
In The Last Decade
David Wilkie
8 papers receiving 431 citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Pathology and Forensic Medicine 270
- Rheumatology 99
- Neurology 91
- Molecular Biology 73
- Neurology 63
Countries citing papers authored by David Wilkie
This map shows the geographic impact of David Wilkie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wilkie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wilkie more than expected).
Fields of papers citing papers by David Wilkie
This network shows the impact of papers produced by David Wilkie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wilkie. The network helps show where David Wilkie may publish in the future.
Co-authorship network of co-authors of David Wilkie
This figure shows the co-authorship network connecting the top 25 collaborators of David Wilkie. A scholar is included among the top collaborators of David Wilkie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Wilkie. David Wilkie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 12 | |
| 3 | 6 | |
| 4 | 5 | |
| 5 | 89 | |
| 6 | 9 | |
| 7 | Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trialbreakdown → | 304 |
| 8 | 6 | |
| 9 | 13 |
About David Wilkie
David Wilkie is a scholar working on Pathology and Forensic Medicine, Health and Neurology, having authored 9 papers that have together received 444 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (5 papers), Patient-Provider Communication in Healthcare (3 papers) and Vaccine Coverage and Hesitancy (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (270 citations), Developmental Neuroscience (48 citations) and Neurology (63 citations). David Wilkie has collaborated with scholars based in United Kingdom, Italy and Germany. Frequent co-authors include Richard Nicholas, Jeremy Chataway, Chris Frost, Dennis Chan, Casper Nielsen, Nadine Schuerer, Ali Alsanousi, K.R. Hunter, Nick C. Fox and Charles R. M. Bangham. Their work appears in journals such as The Lancet, Neurology and The Lancet Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.